Select Guide Rating

• IntroductionNanomaterials Used in Inhaled Pulmonary Delivery SystemsInhaled Nanoliposomes for Treating Lung Disease Including a Case Study of Amikacin Liposome Inhalation Suspension (ALIS)Natural Killer Cells-derived Exosomes as Delivery Systems for Overcoming Resistance in NSCLCInhaled Formulations of mRNA – Lipid Nanoparticles (LNPs): Barriers and Formulation StrategiesNanocharacterization of Pharmaceutical Inhalable ParticlesMulti-stage Cascade Impactors: Their Use and Limitations for the Development and Commercialization of Inhaled Pharmaceuticals Containing Formulations Based on NanotechnologyDissolution Testing for Inhaled Nanoparticlulate Drug Delivery SystemsPulmonary Surfactants and Pulmonary Drug Design and DeliveryHarnessing Inhaled Nanoparticles for Enhanced Pharmacokinetics and Pharmacodynamics of DrugsInteractions of Nanoparticles with Structures of the Respiratory System, Nanoparticle Endocytosis by Cells and Cell ResponsesPolymeric Nanoparticles Targeting Lung Innate Immune CellsInhalable Nanoparticles for Lung ImmunotherapyGeneral Conclusion

Select Guide Rating

• IntroductionNanomaterials Used in Inhaled Pulmonary Delivery SystemsInhaled Nanoliposomes for Treating Lung Disease Including a Case Study of Amikacin Liposome Inhalation Suspension (ALIS)Natural Killer Cells-derived Exosomes as Delivery Systems for Overcoming Resistance in NSCLCInhaled Formulations of mRNA – Lipid Nanoparticles (LNPs): Barriers and Formulation StrategiesNanocharacterization of Pharmaceutical Inhalable ParticlesMulti-stage Cascade Impactors: Their Use and Limitations for the Development and Commercialization of Inhaled Pharmaceuticals Containing Formulations Based on NanotechnologyDissolution Testing for Inhaled Nanoparticlulate Drug Delivery SystemsPulmonary Surfactants and Pulmonary Drug Design and DeliveryHarnessing Inhaled Nanoparticles for Enhanced Pharmacokinetics and Pharmacodynamics of DrugsInteractions of Nanoparticles with Structures of the Respiratory System, Nanoparticle Endocytosis by Cells and Cell ResponsesPolymeric Nanoparticles Targeting Lung Innate Immune CellsInhalable Nanoparticles for Lung ImmunotherapyGeneral Conclusion

Select Guide Rating

• IntroductionNanomaterials Used in Inhaled Pulmonary Delivery SystemsInhaled Nanoliposomes for Treating Lung Disease Including a Case Study of Amikacin Liposome Inhalation Suspension (ALIS)Natural Killer Cells-derived Exosomes as Delivery Systems for Overcoming Resistance in NSCLCInhaled Formulations of mRNA – Lipid Nanoparticles (LNPs): Barriers and Formulation StrategiesNanocharacterization of Pharmaceutical Inhalable ParticlesMulti-stage Cascade Impactors: Their Use and Limitations for the Development and Commercialization of Inhaled Pharmaceuticals Containing Formulations Based on NanotechnologyDissolution Testing for Inhaled Nanoparticlulate Drug Delivery SystemsPulmonary Surfactants and Pulmonary Drug Design and DeliveryHarnessing Inhaled Nanoparticles for Enhanced Pharmacokinetics and Pharmacodynamics of DrugsInteractions of Nanoparticles with Structures of the Respiratory System, Nanoparticle Endocytosis by Cells and Cell ResponsesPolymeric Nanoparticles Targeting Lung Innate Immune CellsInhalable Nanoparticles for Lung ImmunotherapyGeneral Conclusion